Newsletter Subscription

Saturday, Nov 28, 2015

Implant Sciences Signs Testing Agreements for Quantum Sniffer QS-B220

  • Explosives and Narcotics Trace Detector to Be Deployed at Airports and Air Cargo Facilities
Wilmington, MA - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced it has signed agreements with key end-user sites in the United States, Asia, and South America to test its newly launched Quantum Sniffer(TM) QS-B220 bench-top explosives and narcotics trace detector. The systems will be deployed in actual operational environments in both airport security and air cargo screening facilities.

"We are pleased with the enthusiastic response the QS-B220 is receiving from the user community. Containing no radioactive materials, Implant Sciences' products screen passengers and cargo without health or environmental risks," stated Implant Sciences CEO, Glenn D. Bolduc.

Related Research on
C4ISR Market - Analysis & Forecast to 2014 - 2020

Todd Silvestri, Vice President of Product Development added, "The QS-B220 has been designed to meet or exceed all TSA requirements. With automatic calibration, high throughput, and low maintenance needs, the system is ideally suited for security screening applications."

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Implant Sciences Corp.

Published on ASDNews: Jun 28, 2011


Border Security Conference

Feb 17 - 18, 2016 - Rome, Italy

Register More info

Military Space Situational Awareness Conference

Apr 18 - 19, 2016 - London, United Kingdom

Register More info

© 2004-2015 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs